Market Research Logo

Australia Intraocular Lens (IOL) Market Outlook to 2022

Australia Intraocular Lens (IOL) Market Outlook to 2022

Summary

GlobalData’s new report, Australia Intraocular Lens (IOL) Market Outlook to 2022, provides key market data on the Australia Intraocular Lens (IOL) market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Intraocular Lens (IOL) market segements - Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the Australia Intraocular Lens (IOL) market.
  • Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Intraocular Lens (IOL) Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Intraocular Lens (IOL) Market, Australia
3.1 Intraocular Lens (IOL) Market, Australia, Revenue ($m), 2008-2015
3.2 Intraocular Lens (IOL) Market, Australia, Revenue ($m), 2015-2022
3.2.1 Foldable IOL Market, Australia, Revenue ($m), by Segment, 2008-2015
3.2.2 Foldable IOL Market, Australia, Revenue ($m), by Segment, 2015-2022
3.3 Intraocular Lens (IOL) Market, Australia, Volume (Units), 2008-2015
3.4 Intraocular Lens (IOL) Market, Australia, Volume (Units), 2015-2022
3.4.1 Foldable IOL Market, Australia, Volume (Units), by Segment, 2008-2015
3.4.2 Foldable IOL Market, Australia, Volume (Units), by Segment, 2015-2022
3.5 Intraocular Lens (IOL) Market, Australia, Average Price ($), 2008-2022
3.6 Intraocular Lens (IOL) Market, Australia, Distribution Share by Revenue ($m), 2014-2015
3.7 Intraocular Lens (IOL) Market, Australia, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in Australia, Intraocular Lens (IOL) Market
4.1 Hoya Corporation
4.1.1 Company Overview
4.2 Bausch & Lomb Inc
4.2.1 Company Overview
4.3 Abbott Medical Optics Inc
4.3.1 Company Overview
4.4 Carl Zeiss AG
4.4.1 Company Overview
4.5 STAAR Surgical Company
4.5.1 Company Overview
4.6 Alcon, Inc.
4.6.1 Company Overview
5 Intraocular Lens (IOL) Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Apr 12, 2016: Teva to Present Data on SD-809 (deutetrabenazine) at 68th AAN Annual Meeting
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Company Share Analysis
7.1.5 Distribution Share Analysis
7.1.6 Benchmarking
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Incontinence Devices - Pipeline Products by Stage of Development
Table 2: Incontinence Devices - Pipeline Products by Segment
Table 3: Incontinence Devices - Pipeline Products by Territory
Table 4: Incontinence Devices - Pipeline Products by Regulatory Path
Table 5: Incontinence Devices - Pipeline Products by Estimated Approval Date
Table 6: Incontinence Devices - Ongoing Clinical Trials
Table 7: Incontinence Devices Companies - Pipeline Products by Stage of Development
Table 8: Incontinence Devices - Pipeline Products by Stage of Development
Table 9: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Drug Coated Catheter - Product Status
Table 11: Drug Coated Catheter - Product Description
Table 12: AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: SOLVE - Product Status
Table 14: SOLVE - Product Description
Table 15: Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Biowing - Product Status
Table 17: Biowing - Product Description
Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Next Generation Sling System - Product Status
Table 20: Next Generation Sling System - Product Description
Table 21: Pathfinder RP - Product Status
Table 22: Pathfinder RP - Product Description
Table 23: Pathfinder TOT - Product Status
Table 24: Pathfinder TOT - Product Description
Table 25: SIS Sling System - Product Status
Table 26: SIS Sling System - Product Description
Table 27: Solyx I Sling System - Product Status
Table 28: Solyx I Sling System - Product Description
Table 29: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Cerashield Coated Silicone Urinary Catheter - Product Status
Table 31: Cerashield Coated Silicone Urinary Catheter - Product Description
Table 32: Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 33: SpeediCath Flex Coude - Product Status
Table 34: SpeediCath Flex Coude - Product Description
Table 35: Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 36: UTROL Bionic Sphincter - Product Status
Table 37: UTROL Bionic Sphincter - Product Description
Table 38: Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview
Table 39: The Pocket - Product Status
Table 40: The Pocket - Product Description
Table 41: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Implantable Wireless Sphincter System - Product Status
Table 43: Implantable Wireless Sphincter System - Product Description
Table 44: Ecole Polytechnique de Montreal Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Bladder Implant - Product Status
Table 46: Bladder Implant - Product Description
Table 47: Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Wearable Therapeutic Device - Product Status
Table 49: Wearable Therapeutic Device - Product Description
Table 50: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 51: TranStim Transdermal Neuromodulation System - Product Status
Table 52: TranStim Transdermal Neuromodulation System - Product Description
Table 53: Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Accessa - Female Urge Incontinence - Product Status
Table 55: Accessa - Female Urge Incontinence - Product Description
Table 56: CONTINUUM Device - Product Status
Table 57: CONTINUUM Device - Product Description
Table 58: TOPAS Sling System - Product Status
Table 59: TOPAS Sling System - Product Description
Table 60: UroVive Self-Contained Micro-Balloon System - Product Status
Table 61: UroVive Self-Contained Micro-Balloon System - Product Description
Table 62: EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Implantable Device - Urinary Incontinence - Product Status
Table 64: Implantable Device - Urinary Incontinence - Product Description
Table 65: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Self-Sterilizing Urinary Catheter - Product Status
Table 67: Self-Sterilizing Urinary Catheter - Product Description
Table 68: Ergoresearch Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Urinary Disorders Implant - Product Status
Table 70: Urinary Disorders Implant - Product Description
Table 71: Ethicon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 72: GYNECARE SUI Sling Next Generation - Product Status
Table 73: GYNECARE SUI Sling Next Generation - Product Description
Table 74: Facet Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Periurethral Device - Product Status
Table 76: Periurethral Device - Product Description
Table 77: FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Flexiprobe Device - Product Status
Table 79: Flexiprobe Device - Product Description
Table 80: Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Floelle Device - Product Status
Table 82: Floelle Device - Product Description
Table 83: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Anti-biofilm Urological Catheter - Product Status
Table 85: Anti-biofilm Urological Catheter - Product Description
Table 86: Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Disposable Device - Fecal Incontinence - Product Status
Table 88: Disposable Device - Fecal Incontinence - Product Description
Table 89: Forconti Medical Ltd. - Ongoing Clinical Trials Overview
Table 90: Disposable Device - Fecal Incontinence - Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study
Table 91: Future Path Medical Holding, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 92: UroSense Essential - Product Status
Table 93: UroSense Essential - Product Description
Table 94: GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 95: UriTop-F - Product Status
Table 96: UriTop-F - Product Description
Table 97: GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Aroyo artificial urinary sphincter - Product Status
Table 99: Aroyo artificial urinary sphincter - Product Description
Table 100: Fecal Incontinence Device - Product Status
Table 101: Fecal Incontinence Device - Product Description
Table 102: Implantable Incontinence Device - Women - Product Status
Table 103: Implantable Incontinence Device - Women - Product Description
Table 104: GT Urological, LLC - Ongoing Clinical Trials Overview
Table 105: Aroyo artificial urinary sphincter - A Prospective, Non-randomized, Multi-center Clinical Investigation of the Safety and Performance of GT UroLogIcal, LLC's ArtiFicial Urinary Sphincter (RELIEF II)
Table 106: Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview
Table 107: MAXAM Pelvic Floor Device - Product Status
Table 108: MAXAM Pelvic Floor Device - Product Description
Table 109: Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Continent Ostomy System - Product Status
Table 111: Continent Ostomy System - Product Description
Table 112: Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Next Gen Yuririn USH-052 Scanner - Product Status
Table 114: Next Gen Yuririn USH-052 Scanner - Product Description
Table 115: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 116: NexSite Drainage Catheter - Product Status
Table 117: NexSite Drainage Catheter - Product Description
Table 118: Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Time-Delayed Valve System - Product Status
Table 120: Time-Delayed Valve System - Product Description
Table 121: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Incontinence Prosthesis - Product Status
Table 123: Incontinence Prosthesis - Product Description
Table 124: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Regen Sling - Product Status
Table 126: Regen Sling - Product Description
Table 127: Medprin Regenerative Medical Technologies Co Ltd - Ongoing Clinical Trials Overview
Table 128: Regen Sling - A Multi-center, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Regen Sling Treatment for Female Patients with Stress Urinary Incontinence
Table 129: Minnesota Medical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Fecal Incontinence Management Device - Product Status
Table 131: Fecal Incontinence Management Device - Product Description
Table 132: MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 133: ARTUS - Product Status
Table 134: ARTUS - Product Description
Table 135: Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview
Table 136: Urination Management System - Product Status
Table 137: Urination Management System - Product Description
Table 138: NexHand Pipeline Products & Ongoing Clinical Trials Overview
Table 139: Stress Urinary Incontinence Device - Product Status
Table 140: Stress Urinary Incontinence Device - Product Description
Table 141: Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 142: Uro-Ease - Product Status
Table 143: Uro-Ease - Product Description
Table 144: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 145: Female Urinary Incontinence Device - Product Status
Table 146: Female Urinary Incontinence Device - Product Description
Table 147: Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Flow Control Device - Fecal Incontinence - Product Status
Table 149: Flow Control Device - Fecal Incontinence - Product Description
Table 150: Politano-Sayet-Sutherland Flow Control Device - Product Status
Table 151: Politano-Sayet-Sutherland Flow Control Device - Product Description
Table 152: Prosurg, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 153: ConstrictX - Product Status
Table 154: ConstrictX - Product Description
Table 155: Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Biomaterial-Based Incontinence Device - Product Status
Table 157: Biomaterial-Based Incontinence Device - Product Description
Table 158: Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Incontinence Device - Product Status
Table 160: Incontinence Device - Product Description
Table 161: Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
Table 162: Sensurine - Product Status
Table 163: Sensurine - Product Description
Table 164: Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 165: Home Care Incontinance Device - Product Status
Table 166: Home Care Incontinance Device - Product Description
Table 167: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 168: Foley Urinary Catheter - Product Status
Table 169: Foley Urinary Catheter - Product Description
Table 170: Solace Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 171: Vesair Bladder Control System - Product Status
Table 172: Vesair Bladder Control System - Product Description
Table 173: Solace Therapeutics - Ongoing Clinical Trials Overview
Table 174: Vesair Bladder Control System - An Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects with Stress Urinary Incontinence
Table 175: Vesair Bladder Control System - Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects with Stress Urinary Incontinence
Table 176: Suneva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 177: ArteSure - Product Status
Table 178: ArteSure - Product Description
Table 179: Svenska Cellulosa Aktiebolaget Pipeline Products & Ongoing Clinical Trials Overview
Table 180: TENA Identifi - Product Status
Table 181: TENA Identifi - Product Description
Table 182: Svenska Cellulosa Aktiebolaget - Ongoing Clinical Trials Overview
Table 183: TENA Identifi - A Randomized, Controlled Trial of Effectiveness of a Smart Sensor for Continence Care: The ARCTICC Study
Table 184: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 185: Pre-Activated Female Intermittent Catheter - Product Status
Table 186: Pre-Activated Female Intermittent Catheter - Product Description
Table 187: Pre-Activated Male Intermittent Catheter - Product Status
Table 188: Pre-Activated Male Intermittent Catheter - Product Description
Table 189: Tengion Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 190: Neo Bladder Augment - Urge Incontinence - Product Status
Table 191: Neo Bladder Augment - Urge Incontinence - Product Description
Table 192: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 193: Confidence Building Incontinence Pad - Product Status
Table 194: Confidence Building Incontinence Pad - Product Description
Table 195: Gelift - Product Status
Table 196: Gelift - Product Description
Table 197: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 198: AdvanceCath Catheter - Product Status
Table 199: AdvanceCath Catheter - Product Description
Table 200: Urinary Assist Device - Product Status
Table 201: Urinary Assist Device - Product Description
Table 202: Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview
Table 203: Pelvic Floor Measurement Device - Product Status
Table 204: Pelvic Floor Measurement Device - Product Description
Table 205: University of Basel Pipeline Products & Ongoing Clinical Trials Overview
Table 206: Artificial Sphincter Implant - Product Status
Table 207: Artificial Sphincter Implant - Product Description
1.2 List of Figures
Figure 1: Intraocular Lens (IOL) Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Intraocular Lens (IOL) Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Foldable IOL Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Foldable IOL Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 5: Intraocular Lens (IOL) Market, Australia, Volume (Units), Historic, 2008-2015
Figure 6: Intraocular Lens (IOL) Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 7: Foldable IOL Market, Australia, Volume (Units), Historic, 2008-2015
Figure 8: Foldable IOL Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 9: Intraocular Lens (IOL) Market, Australia, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report